Nephros/$NEPH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Nephros
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
- Ticker
- $NEPH
- Sector
- Industrials
- Primary listing
- NASDAQ
- Employees
- 36
- Headquarters
- South Orange, United States
- Website
- www.nephros.com
Nephros Metrics
BasicAdvanced
$33M
17.27
$0.18
-
-
Price and volume
Market cap
$33M
52-week high
$6.42
52-week low
$2.66
Average daily volume
61K
Financial strength
Current ratio
5.503
Quick ratio
3.374
Long term debt to equity
0.028
Total debt to equity
0.062
Interest coverage (TTM)
1,829.00%
Profitability
EBITDA (TTM)
1.952
Gross margin (TTM)
60.55%
Net profit margin (TTM)
8.86%
Operating margin (TTM)
8.48%
Effective tax rate (TTM)
0.68%
Revenue per employee (TTM)
$600,000
Management effectiveness
Return on assets (TTM)
8.01%
Return on equity (TTM)
16.95%
Valuation
Price to earnings (TTM)
17.273
Price to revenue (TTM)
1.53
Price to book
2.66
Price to tangible book (TTM)
2.94
Price to free cash flow (TTM)
-36.274
Free cash flow yield (TTM)
-2.76%
Free cash flow per share (TTM)
-0.085
Growth
Revenue change (TTM)
20.36%
Earnings per share change (TTM)
28.00%
3-year revenue growth (CAGR)
16.80%
10-year revenue growth (CAGR)
26.32%
3-year earnings per share growth (CAGR)
-5.08%
10-year earnings per share growth (CAGR)
-12.02%
Nephros Financial Performance
Revenues and expenses
Nephros Earnings Performance
Company profitability
Upcoming events
No upcoming events
Nephros News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.